Research and Markets: Metastatic Cancer - Pipeline Review, H2 2013

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/nv7436/metastatic_cancer) has announced the addition of the "Metastatic Cancer - Pipeline Review, H2 2013" report to their offering.

'Metastatic Cancer - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Cancer.

Scope

- A snapshot of the global therapeutic scenario for Metastatic Cancer.

- A review of the Metastatic Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Metastatic Cancer pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned

Bristol-Myers Squibb Company

Boehringer Ingelheim GmbH

F. Hoffmann-La Roche Ltd.

Amgen Inc.

Eli Lilly and Company

Merck & Co., Inc.

ZIOPHARM Oncology, Inc.

Aphios Corporation

SuperGen, Inc.

Celgene Corporation

AntiCancer, Inc.

Merck KGaA

EntreMed, Inc.

Circadian Technologies Limited

TapImmune Inc.

Hanall Pharmaceutical Co., Ltd.

Galapagos NV

Cancer Research Technology Limited

Glycotope GmbH

Altor BioScience Corporation

Provecs Medical GmbH

Alethia Biotherapeutics Inc.

Five Prime Therapeutics, Inc.

Merrimack Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, LLC

MSM Protein Technologies, Inc.

Vascular Biogenics Ltd.

Advenchen Laboratories, LLC

Globeimmune, Inc.

and many more...

For more information visit http://www.researchandmarkets.com/research/nv7436/metastatic_cancer

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology